SAMC
TARO

Shinko Asset Management Company’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Shinko Asset Management Company’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2K Hold
20
– – ﹤0.01% 879
2016
Q2 		$3K Hold
20
– – ﹤0.01% 886
2016
Q1 		$3K Buy
+20
New +$2.84K ﹤0.01% 888

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Shinko Asset Management Company's TARO Position: Q3 2016 in Review

Shinko Asset Management Company held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q3 2016 at 20 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Shinko Asset Management Company first reported a position in TARO in Q1 2016 and has held it in 3 quarters since. The position peaked at $3K in Q2 2016. 162 funds tracked by Wall St. Rank hold TARO as of Q3 2016.

  • Shinko Asset Management Company held 20 shares of Taro Pharmaceutical Industries Ltd. worth $2K as of Q3 2016.
  • Shinko Asset Management Company left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q3 2016.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #879 holding.
  • Shinko Asset Management Company first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and has held it in 3 quarters since.
  • Shinko Asset Management Company's Taro Pharmaceutical Industries Ltd. position peaked at $3K in Q2 2016.
  • 162 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.